Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

被引:468
作者
Pépin, J
Valiquette, L
Cossette, B
机构
[1] CHU Sherbrooke, Dept Pharm, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada
关键词
D O I
10.1503/cmaj.050978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Since 2002 an epidemic of Clostridium difficile - associated disease (CDAD) caused by a hypervirulent toxinotype III ribotype 027 strain has spread to many hospitals in Quebec. The strain has also been found in the United States, the United Kingdom and the Netherlands. The effects of this epidemic on mortality and duration of hospital stay remain unknown. We measured these effects among patients admitted to a hospital in Quebec during 2003 and 2004. Methods: We compared mortality and total length of hospital stay among inpatients in whom nosocomial CDAD developed and among control subjects without CDAD matched for sex, age, Charlson Comorbidity Index score and length of hospital stay up to the diagnosis of CDAD in the corresponding case. Results: Thirty days after diagnosis 23.0% (37/161) of the patients with CDAD had died, compared with 7.0% (46/656) of the matched control subjects (p< 0.001). Twelve months after diagnosis, mortality was 37.3% (60/161) among patients with CDAD and 20.6% (135/656) among the control subjects ( p< 0.001), for a cumulative attributable mortality of 16.7% (95% confidence interval 8.6% - 25.2%). Each case of nosocomial CDAD led, on average, to 10.7 additional days in hospital. Interpretation: This study documented a high attributable mortality among elderly patients with CDAD mostly caused by a hypervirulent strain, which represents a dramatic change in the severity of this infection.
引用
收藏
页码:1037 / 1042
页数:6
相关论文
共 29 条
[1]   Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches [J].
Alfa, MJ ;
Du, T ;
Beda, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) :2076-2080
[2]  
[Anonymous], SURV DIARRH ASS CLOS
[3]   VALIDATION OF A COMBINED COMORBIDITY INDEX [J].
CHARLSON, M ;
SZATROWSKI, TP ;
PETERSON, J ;
GOLD, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251
[4]   Fulminant Clostridium difficile:: An underappreciated and increasing cause of death and complications [J].
Dallal, RM ;
Harbrecht, BG ;
Boujoukas, AJ ;
Sirio, CA ;
Farkas, LM ;
Lee, KK ;
Simmons, RL .
ANNALS OF SURGERY, 2002, 235 (03) :363-372
[5]  
*DEP HLTH, 2005, COMMUN DIS REP CDR W, V15, P1
[6]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[7]   Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:: cohort and case-control studies [J].
Dial, S ;
Alrasadi, K ;
Manoukian, C ;
Huang, A ;
Menzies, D .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (01) :33-38
[8]   C. difficile: by the numbers [J].
Eggertson, L .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (11) :1331-1332
[9]  
GAULIN C, 2004, SPEC S C DIFF ASS ME
[10]   Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. [J].
Goossens, H ;
Ferech, M ;
Stichele, RV ;
Elseviers, M .
LANCET, 2005, 365 (9459) :579-587